Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Long-Term Investments (2016 - 2023)

BioCorRx's Long-Term Investments history spans 11 years, with the latest figure at $44520.0 for Q2 2023.

  • For Q2 2023, Long-Term Investments changed 0.0% year-over-year to $44520.0; the TTM value through Jun 2023 reached $44520.0, changed 0.0%, while the annual FY2022 figure was $44520.0, 0.0% changed from the prior year.
  • Long-Term Investments for Q2 2023 was $44520.0 at BioCorRx, roughly flat from $44520.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $53793.0 in Q3 2019 and bottomed at $13422.0 in Q1 2019.
  • The 5-year median for Long-Term Investments is $44520.0 (2020), against an average of $41292.7.
  • The largest annual shift saw Long-Term Investments surged 300.78% in 2019 before it decreased 17.24% in 2020.
  • A 5-year view of Long-Term Investments shows it stood at $41936.0 in 2019, then increased by 6.16% to $44520.0 in 2020, then changed by 0.0% to $44520.0 in 2021, then changed by 0.0% to $44520.0 in 2022, then changed by 0.0% to $44520.0 in 2023.
  • Per Business Quant, the three most recent readings for BICX's Long-Term Investments are $44520.0 (Q2 2023), $44520.0 (Q1 2023), and $44520.0 (Q4 2022).